For: | Frommer L, Kahaly GJ. Type 1 diabetes and associated autoimmune diseases. World J Diabetes 2020; 11(11): 527-539 [PMID: 33269064 DOI: 10.4239/wjd.v11.i11.527] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v11/i11/527.htm |
Number | Citing Articles |
1 |
Vazgen Minasian, Maryam Nazari. The association between type 1 diabetes and exercise/physical activity and prolongation of the honeymoon phase in patients. Life Sciences 2023; 332: 122114 doi: 10.1016/j.lfs.2023.122114
|
2 |
Chaitanya Sambangi, Patrice Collins, Jacqueline Chan, Julisa Patel. Autoimmune Polyendocrinopathy in a Pediatric Patient Presenting With Multisystem Inflammatory Syndrome in Children (MIS-C). Cureus 2023; doi: 10.7759/cureus.38407
|
3 |
Antonietta Robino, Elena Bevilacqua, Luana Aldegheri, Andrea Conti, Valentina Bazzo, Gianluca Tornese, Eulalia Catamo. Next-generation sequencing reveals additional HLA class I and class II alleles associated with type 1 diabetes and age at onset. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1427349
|
4 |
Livia M. R. Marcon, Carmine G. Fanelli, Riccardo Calafiore, Suat Simsek. Type 1 Diabetes (T1D) and Latent Autoimmune Diabetes in Adults (LADA): The Difference Between a Honeymoon and a Holiday. Case Reports in Endocrinology 2022; 2022: 1 doi: 10.1155/2022/9363543
|
5 |
Ravindra Bachate, Manali Purohit. USER-CENTRIC DIGITAL SOLUTION FOR DIABETIC PATIENTS. ShodhKosh: Journal of Visual and Performing Arts 2024; 5(ICETDA24) doi: 10.29121/shodhkosh.v5.iICETDA24.2024.1277
|
6 |
Bantayehu Addis Tegegne, Adane Adugna, Aderaw Yenet, Wubetu Yihunie Belay, Yared Yibeltal, Abebe Dagne, Zigale Hibstu Teffera, Gashaw Azanaw Amare, Desalegn Abebaw, Haymanot Tewabe, Rahel Belete Abebe, Tirsit Ketsela Zeleke. A critical review on diabetes mellitus type 1 and type 2 management approaches: from lifestyle modification to current and novel targets and therapeutic agents. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1440456
|
7 |
Graeme Gardner, Christopher A. Fraker. Natural Killer Cells as Key Mediators in Type I Diabetes Immunopathology. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.722979
|
8 |
Marilia Brito Gomes, Fernanda Oliveira Braga, Karla Guerra Drummond, André Pinheiro, Franz Leal, Luís Cristóvão Porto, Livia Leite Ferreira, Geraldo da Rocha Castelar Pinheiro, Carlos Antonio Negrato. Prevalence of autoimmune diseases in an admixed population of patients with type 1 diabetes: a multicenter study in Brazil. Diabetology & Metabolic Syndrome 2024; 16(1) doi: 10.1186/s13098-024-01274-3
|
9 |
Kevin M. Harris, Madison A. Clements, Andrew J. Kwilasz, Linda R. Watkins. T cell transgressions: Tales of T cell form and function in diverse disease states. International Reviews of Immunology 2022; 41(5): 475 doi: 10.1080/08830185.2021.1921764
|
10 |
David Morris. Looking out for other autoimmune conditions in type 1 diabetes. Independent Nurse 2022; 2022(5): 13 doi: 10.12968/indn.2022.5.13
|
11 |
Aaron Shengting Mai, Brendan Jen-Wei Tan, Qiao-Yang Sun, Eng-King Tan. Association between Type 1 Diabetes Mellitus and Parkinson’s Disease: A Mendelian Randomization Study. Journal of Clinical Medicine 2024; 13(2): 561 doi: 10.3390/jcm13020561
|
12 |
Lara Frommer, Jochem König, Sofia Chatzidou, Georgios Chionos, Jan Längericht, George J. Kahaly. Recurrence risk of autoimmune thyroid and endocrine diseases. Best Practice & Research Clinical Endocrinology & Metabolism 2023; 37(2): 101636 doi: 10.1016/j.beem.2022.101636
|